www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News URGENT: Two Palestinians killed by Israeli soldiers in West Bank    URGENT: EU prepares ban on Croatian poultry    URGENT: Bird flu virus confirmed in Croatia: report    URGENT: Syrian security forces arrest militants    Urgent: Parrot with bird flu found dead in Britain    Urgent: Suspicious package found inside vehicle near US Capitol     
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Online marketplace of Manufacturers & Wholesalers
   News Photos Voice People BizChina Feature About us   
Hungarian bird flu vaccine proves effective in humans
www.chinaview.cn 2005-10-22 10:44:41

    BUDAPEST, Oct. 21 (Xinhuanet) -- Hungary's bird flu vaccine currently on trial has proved effective, Jeno Racz, the country's health minister, said on Friday.

    "Now we can confirm unequivocally that the vaccine is effective,"Racz said, adding that an antibody was found in the blood of the vaccinated people, including himself and two other senior health officials.

    The vaccine was effective against the H5N1 variant of the virusresponsible for the disease that could spread from animals to humans.

    But it is not yet clear if the vaccine will be useful in the case of a pandemic of bird flu communicated between humans, said Ferenc Zimonyi, the organization director of Omninvest Ltd., the company that developed the vaccine.

    Zimonyi said the vaccine was made using a completely novel technology, involving the application of the full inactivated flu virus, rather than certain components. And the vaccine also has a special agent designed to increase its efficiency.

    Rights to the vaccine are jointly shared by the government and vaccine maker Omninvest Ltd., a local newspaper quoted government spokesman Andras Batiz as saying Friday.

    Countries that have shown interest in the vaccine include Indonesia, the Philippines, Russia, Ukraine, Mongolia, the United States, Britain and Germany, Batiz said.

    Human testing of the new drug started in late September on morethan 100 volunteers working in the health-care sector. Enditem

  Related Story
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.